K2 Principal Fund’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

K2 Principal Fund’s Portfolio NITE Stock Details NITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-34,275	Closed	-$870K	–	391
2019 Q1	$870K	Buy	+34,275	New	+$606K	0.11%	199

K2 Principal Fund's NITE Position: Q2 2019 in Review

K2 Principal Fund sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q2 2019, closing a stake of 34,275 shares — an estimated $870K sold.

K2 Principal Fund first reported a position in NITE in Q1 2019 and held it in 1 quarter. The position peaked at $870K in Q1 2019. 0 funds tracked by Wall St. Rank hold NITE as of Q2 2019.

K2 Principal Fund reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
K2 Principal Fund sold 34,275 Nightstar Therapeutics plc American Depositary Shares shares in Q2 2019, an estimated $870K.
K2 Principal Fund first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q1 2019 and held it in 1 quarter.
K2 Principal Fund's Nightstar Therapeutics plc American Depositary Shares position peaked at $870K in Q1 2019.
0 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q2 2019.

Based on K2 Principal Fund's 13F filing for Q2 2019, filed 14 Aug 2019.